Zoetis Releases 2024 Sustainability Progress Update
5 juni, 15:00
5 juni, 15:00
Zoetis published its 2024 Sustainability Progress Update “Advancing Sustainability in Animal Health for a Better Future” to highlight the company’s continued progress toward achieving its Driven to Care aspirations. The publication represents Zoetis’ fifth year reporting on its purpose-driven actions across three pillars – Communities, Animals and the Planet – that strengthen its business by creating long-term value, enhancing stakeholder trust, and supporting sustainable growth.
“Zoetis contributes to a healthier future for communities, animals and the planet thanks to our colleagues who demonstrate their commitment to the Driven to Care strategy and are empowered to advance our company’s purpose,” said Jeannette Ferran Astorga, Executive Vice President, Corporate Affairs, and Chief Sustainability Officer at Zoetis and President of the Zoetis Foundation. “By embedding our sustainability strategy across our business, and through purposeful partnerships with our customers and other stakeholders, our actions address challenges at the intersection of people, animals and the environment.”
Highlights of the company’s progress in 2024 include:
Communities – Care and Collaboration
Animals – Innovation in Animal Health
Planet – The Drive to Protect our Planet
For more detailed disclosures on the company’s sustainability programs, practices and policies, please download Zoetis’ 2024 Sustainability Progress Update or visit www.zoetis.com/sustainability. Zoetis will continue to share updates on its sustainability activities, including progress against its Driven to Care aspirations, and report annually.
About Zoetis
As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After innovating ways to predict, prevent, detect, and treat animal illness for more than 70 years, Zoetis continues to stand by those raising and caring for animals worldwide – from veterinarians and pet owners to livestock producers. The company’s leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries. A Fortune 500 company, Zoetis generated revenue of $9.3 billion in 2024 with approximately 13,800 employees. For more information, visit www.zoetis.com.
DISCLOSURE NOTICES
Forward-Looking Statements: This press release and the 2024 Sustainability Progress Update (including the 2024 SASB and ESG Index) contain forward-looking statements which reflect the current views of Zoetis with respect to: our progress toward our Driven to Care aspirations; our business plans or prospects; expectations regarding future operating or financial performance; the plans and future work of the Zoetis Foundation, and other future events. These statements are not guarantees of future performance or actions. Forward-looking statements are subject to risks and uncertainties. If one or more of these risks or uncertainties materialize, or if management's underlying assumptions prove to be incorrect, actual results may differ materially from those contemplated by a forward-looking statement. Forward-looking statements speak only as of the date on which they are made. Zoetis expressly disclaims any obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. A further list and description of risks, uncertainties and other matters can be found in our most recent Annual Report on Form 10-K, including in the sections thereof captioned “Forward-Looking Statements and Factors That May Affect Future Results” and “Item 1A. Risk Factors,” in our Quarterly Reports on Form 10-Q and in our Current Reports on Form 8-K. These filings and subsequent filings are available online at www.sec.gov, www.zoetis.com, or on request from Zoetis.
All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted.
See the footnotes within our 2024 Sustainability Progress Update for more details regarding all calculations.
ZTS-COR
ZTS-IR
View source version on businesswire.com: https://www.businesswire.com/news/home/20250604519690/en/
5 juni, 15:00
Zoetis published its 2024 Sustainability Progress Update “Advancing Sustainability in Animal Health for a Better Future” to highlight the company’s continued progress toward achieving its Driven to Care aspirations. The publication represents Zoetis’ fifth year reporting on its purpose-driven actions across three pillars – Communities, Animals and the Planet – that strengthen its business by creating long-term value, enhancing stakeholder trust, and supporting sustainable growth.
“Zoetis contributes to a healthier future for communities, animals and the planet thanks to our colleagues who demonstrate their commitment to the Driven to Care strategy and are empowered to advance our company’s purpose,” said Jeannette Ferran Astorga, Executive Vice President, Corporate Affairs, and Chief Sustainability Officer at Zoetis and President of the Zoetis Foundation. “By embedding our sustainability strategy across our business, and through purposeful partnerships with our customers and other stakeholders, our actions address challenges at the intersection of people, animals and the environment.”
Highlights of the company’s progress in 2024 include:
Communities – Care and Collaboration
Animals – Innovation in Animal Health
Planet – The Drive to Protect our Planet
For more detailed disclosures on the company’s sustainability programs, practices and policies, please download Zoetis’ 2024 Sustainability Progress Update or visit www.zoetis.com/sustainability. Zoetis will continue to share updates on its sustainability activities, including progress against its Driven to Care aspirations, and report annually.
About Zoetis
As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After innovating ways to predict, prevent, detect, and treat animal illness for more than 70 years, Zoetis continues to stand by those raising and caring for animals worldwide – from veterinarians and pet owners to livestock producers. The company’s leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries. A Fortune 500 company, Zoetis generated revenue of $9.3 billion in 2024 with approximately 13,800 employees. For more information, visit www.zoetis.com.
DISCLOSURE NOTICES
Forward-Looking Statements: This press release and the 2024 Sustainability Progress Update (including the 2024 SASB and ESG Index) contain forward-looking statements which reflect the current views of Zoetis with respect to: our progress toward our Driven to Care aspirations; our business plans or prospects; expectations regarding future operating or financial performance; the plans and future work of the Zoetis Foundation, and other future events. These statements are not guarantees of future performance or actions. Forward-looking statements are subject to risks and uncertainties. If one or more of these risks or uncertainties materialize, or if management's underlying assumptions prove to be incorrect, actual results may differ materially from those contemplated by a forward-looking statement. Forward-looking statements speak only as of the date on which they are made. Zoetis expressly disclaims any obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. A further list and description of risks, uncertainties and other matters can be found in our most recent Annual Report on Form 10-K, including in the sections thereof captioned “Forward-Looking Statements and Factors That May Affect Future Results” and “Item 1A. Risk Factors,” in our Quarterly Reports on Form 10-Q and in our Current Reports on Form 8-K. These filings and subsequent filings are available online at www.sec.gov, www.zoetis.com, or on request from Zoetis.
All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted.
See the footnotes within our 2024 Sustainability Progress Update for more details regarding all calculations.
ZTS-COR
ZTS-IR
View source version on businesswire.com: https://www.businesswire.com/news/home/20250604519690/en/
Analys
Danmarks nationaldag
Fondernas placeringar
Inflationen
Investmentbolag
Analys
Danmarks nationaldag
Fondernas placeringar
Inflationen
Investmentbolag
1 DAG %
Senast
Novo Nordisk
5 juni, 16:36
Nordeas miljonärer köper danskt
OMX Stockholm 30
1 DAG %
Senast
2 521,51